Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

EIF4E Antikörper

EIF4E Reaktivität: Human WB, IHC, ELISA, FACS, ICC Wirt: Maus Monoclonal 5D11 unconjugated
Produktnummer ABIN969094
  • Target Alle EIF4E Antikörper anzeigen
    EIF4E (Eukaryotic Translation Initiation Factor 4E (EIF4E))
    Reaktivität
    • 116
    • 57
    • 45
    • 19
    • 5
    • 5
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    Human
    Wirt
    • 99
    • 16
    • 2
    Maus
    Klonalität
    • 92
    • 25
    Monoklonal
    Konjugat
    • 56
    • 9
    • 8
    • 6
    • 6
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser EIF4E Antikörper ist unkonjugiert
    Applikation
    • 95
    • 49
    • 39
    • 27
    • 26
    • 26
    • 17
    • 14
    • 14
    • 13
    • 7
    • 6
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Flow Cytometry (FACS), Immunocytochemistry (ICC)
    Verwendungszweck
    EIF4E Antibody
    Aufreinigung
    Ascitic fluid
    Immunogen
    Purified recombinant fragment of human EIF4E expressed in E. Coli.
    Klon
    5D11
    Isotyp
    IgG1
    Top Product
    Discover our top product EIF4E Primärantikörper
  • Applikationshinweise

    ELISA: 1/10000

    FCM: 1/200 - 1/400

    ICC: 1/200 - 1/1000

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Ascitic fluid containing 0.03 % sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
  • Slepenkov, Korneeva, Rhoads: "Kinetic mechanism for assembly of the m7GpppG.eIF4E.eIF4G complex." in: The Journal of biological chemistry, Vol. 283, Issue 37, pp. 25227-37, (2008) (PubMed).

    Holm, Byrnes, Johnson, Abreo, Sehon, Alley, Meschonat, Md, Li: "A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-negative breast cancer." in: Annals of surgical oncology, Vol. 15, Issue 11, pp. 3207-15, (2008) (PubMed).

  • Target
    EIF4E (Eukaryotic Translation Initiation Factor 4E (EIF4E))
    Andere Bezeichnung
    EIF4E (EIF4E Produkte)
    Hintergrund

    Description: eIF4E, a protein modulates translation of maternal mRNAs in early embryos before the onset of zygotic transcription. eIF4E also influences the overall rate of translation. eIF4E binds to the 7 methyl GTP cap structure of eukaryotic mRNAs. Phosphorylation of eIF4E on serine 209 regulates the affinity of this protein for the 7 methyl GTP cap and/or RNA. Phosphorylation also enhances the interaction of eIF4E with eIF4G, which form a complex known as eIF4F. eIF4E phosphorylation is correlated with increased translational rate in a number of cell types. Several kinases are currently being investigated as potential regulators of eIF4E including PKC and/or the MAP kinase activated Mnk.

    Aliases: CBP, EIF4F, EIF4E1, EIF4EL1, MGC111573, EIF4E

    Molekulargewicht
    25kDa
    Gen-ID
    1977
    HGNC
    1977
    UniProt
    P06730
    Pathways
    BCR Signaling
Kundenservice